Inhibition of aromatase activity in MCF-7aro human breast cancer cells by the natural androgens testosterone and androstenedione
-
Gérard S. Chetrite
Abstract
Background: The human breast contains all the enzymes responsible for local bioformation of estradiol (E2). Two principal pathways are implicated in the last steps of E2 formation: the ‘aromatase’ which transforms androgens into estrogens, and the ‘sulfatase’ which converts estrogen sulfates into active unconjugated estrogens; activities found in both normal and cancerous breast. Aromatase inhibition by anti-aromatase agents is largely used with very positive results in the treatment of breast cancer patients. In this study, the effects of the natural androgens androstenedione and testosterone were explored on aromatase activity in a stable aromatase-expressing estrogen receptor-positive human breast cancer cell line MCF-7aro.
Materials and methods: The cells were incubated with physiological concentrations of [3H]-testosterone (5 nmol/L) alone or in the presence of either testosterone or androstenedione (0.5 and 50 μmol/L) 24 h at 37°C. Cellular radioactivity uptake was determined. [3H]-E2 was characterized by thin-layer chromatography.
Results: The MCF-7aro cells have a very high aromatase activity because conversion of [3H]-testosterone to [3H]-E2 was 3.02±0.17 pmol/mg DNA in non-treated cells. Testosterone, at concentrations of 0.5 and 50 μmol/L, provoked inhibition of E2 formation of 36% and 79%, respectively. The effect of androstenedione at 0.5 and 50 μmol/L was 56% and 76%, respectively.
Conclusion: In breast cancer cells, the natural androgens testosterone and androstenedione, have the capacity to control bioformation of estradiol by blocking aromatase activity. The data can provide important information on the control mechanism of estrogen intratumoral levels and open new possibilities in breast cancer treatment.
©2009 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Editorial
- Editorial
- Mini Review
- The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers
- Review
- Are estradiol metabolites involved in gynaecological carcinogenesis?
- Original articles
- Differential effects of overexpression of ERα and ERβ in MCF10A immortalised, non-transformed human breast epithelial cells
- Visualization of Stat3 and Stat5 transactivation activity with specific response element dependent reporter constructs integrated into lentiviral gene transfer vectors
- Effect of toremifene and ospemifene, compared to acolbifene, on estrogen-sensitive parameters in rat and human uterine tissues
- Inhibition of aromatase activity in MCF-7aro human breast cancer cells by the natural androgens testosterone and androstenedione
Articles in the same Issue
- Editorial
- Editorial
- Mini Review
- The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers
- Review
- Are estradiol metabolites involved in gynaecological carcinogenesis?
- Original articles
- Differential effects of overexpression of ERα and ERβ in MCF10A immortalised, non-transformed human breast epithelial cells
- Visualization of Stat3 and Stat5 transactivation activity with specific response element dependent reporter constructs integrated into lentiviral gene transfer vectors
- Effect of toremifene and ospemifene, compared to acolbifene, on estrogen-sensitive parameters in rat and human uterine tissues
- Inhibition of aromatase activity in MCF-7aro human breast cancer cells by the natural androgens testosterone and androstenedione
